More virtual healthcare means more direct to patient distribution. Read three ways to leverage existing data and infuse trust in your supply chain: https://t.co/RyZIeNwVIp
Congratulations to @Accenture CEO @JulieSweet for being ranked #1 on the 2020 @FortuneMPW Most Powerful Women in Business list. She has used her influence to shape Accenture “and the wider world for the better”—all in a year unlike any other. https://t.co/gSGkeVgFZc
Never get to play with your company’s logo? @Accenture’s 506,000 people can. They’ve always been our brand, and now they’re in our logo—using a personalization tool to celebrate our new “Let there be change” brand campaign. #LetThereBeChange
Before #COVID19, virtual care had yet to go mainstream. But, what about now? See the results of our 2020 #DigitalHealth Consumer Survey. https://t.co/wckdzPx6xV
We not only rely on technology for convenience but have expectations that every entity we interact with will have invested in tech that elevates the customer/patient experience. https://t.co/k0XMdy8rec
The @Accenture brand continues to increase in value, up 15% since last year—now our 9th consecutive year on the @Forbes Most Valuable Brands list. Huge thanks to our clients and to each and every one of our more than 500,000 people—our brand ambassadors! https://t.co/a8ueMD1aCH
What business model should biopharma companies adopt for their cell and gene therapy business? It's Time To Rethink Shoe-Horning Cell And Gene Therapies Into A Pharma Business https://t.co/Pb0TtrE76s #CellTherapy#biopharma#GeneTherapy
The question I'm hearing from #lifesciences CEOs: "How do we better help our patients?" In my latest blog, I share why this is the time to show the world that the industry can be a force for good. https://t.co/ZdbhKZlP2J #COVID19
„Pick winners and scale quickly for making the Digital Lab a reality” says Dr Matt Ellis, Accenture R&D #smartlabexchange in Berlin. @AccentureLifSci @AccentureDACH
“To become a digital leader in #clinicaldevelopment, it is critical to foster a data-driven mindset along with hardwiring new ways of working”, said Marcy Kravet, Merck KGaA during a joint speech with Marc Philipp from #AccentureLifSci at #ScopeEurope
Our latest research shows that a new category - ‘New Science’ - is filling an unmet need to advance the standard of care. Learn more. https://t.co/rrvQgTrftu
“Digitalization in #pharma has a huge business case around #DataAnalytics & continuous manufacturing but setting right priorities on plant level isn’t trivial” says Markus Hayek, Managing Director Life Sciences @AccentureStrat #manupharma@AccentureInd@AccentureLifSci